Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Dermatology

Expert Opinion / Conference Coverage · March 15, 2017

AAD 2017 Annual Meeting: Dr. Robert Brodell’s Take-Aways

Written by
Robert T. Brodell MD, FAAD

 

 Save  Recommend
 Share

Additional Info

  1. Thomas MH, Gutterman LA. J Rheumatol. Methotrexate toxicity in a patient receiving trimethoprim–sulfamethoxazole. 1986;13(2):440-441.

  2. Larsen FG, Jakobsen P, Knudsen J, et al. Conversion of acitretin to etretinate is increased psoriatic patients by ethanol. J Invest Dermatol. 1993;100:623-627.

  3. Talpur R, Ward S, Apisarnthanarax N, et al. Optimizing bexarotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol. 2002;47(5):672-684.

  4. Foster CA, Aston SJ. Propranolol-epinephrine interaction: a potential disaster. Plast Reconstr Surg. 1983;72(1):74-78.

  5. Dzubow LM. J Am Acad Dermatol. 1986;15(1):71-75.

  6. Bettoli V, Borghi A, Mantovani L, et al. Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline. Eur J Dermatol. 2011;21(6):1024-1025.
  7. Antoniou T, Gomes T, Mamdani MM, et al. Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ. 2011;343:d5228.
  8. Antoniou T, Hollands S, Macdonald EM, et al. Canadian Drug Safety and Effectiveness Research Network. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. CMAJ. 2015;187(4):E138-E143.
  9. Excess of Ampicillin Rashes Associated with Allopurinol or Hyperuricemia Boston Collaborative Drug Surveillance Program. N Engl J Med. 1972;286(10):505-507.
  10. Helms SE, Bredle DL, Zajic J, et al. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol. 1997; 36(5 Pt 1 ):705-710.
  11. London BM, Lookingbill DP. Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives. Arch Dermatol. 1994;130(3):392-393.

Disclosure statements are available on the authors' profiles:

Robert Brodell MD, FAAD

Further Reading

Most Read This Week

Recently Updated